- Home
- HNST vs ATXS Comparison
HNST vs ATXS Comparison
Compare HNST & ATXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HNST
- ATXS
- Stock Information
- Founded
- HNST 2012
- ATXS 2008
- Country
- HNST United States
- ATXS United States
- Employees
- HNST N/A
- ATXS N/A
- Industry
- HNST Catalog/Specialty Distribution
- ATXS Biotechnology: Pharmaceutical Preparations
- Sector
- HNST Consumer Discretionary
- ATXS Health Care
- Exchange
- HNST Nasdaq
- ATXS Nasdaq
- Market Cap
- HNST 456.2M
- ATXS 424.4M
- IPO Year
- HNST 2021
- ATXS 2015
- Fundamental
- Price
- HNST $3.95
- ATXS $7.67
- Analyst Decision
- HNST Buy
- ATXS Buy
- Analyst Count
- HNST 5
- ATXS 6
- Target Price
- HNST $6.75
- ATXS $32.00
- AVG Volume (30 Days)
- HNST 3.4M
- ATXS 318.8K
- Earning Date
- HNST 11-11-2025
- ATXS 08-12-2025
- Dividend Yield
- HNST N/A
- ATXS N/A
- EPS Growth
- HNST N/A
- ATXS N/A
- EPS
- HNST 0.06
- ATXS N/A
- Revenue
- HNST $389,783,000.00
- ATXS N/A
- Revenue This Year
- HNST $6.79
- ATXS N/A
- Revenue Next Year
- HNST $4.70
- ATXS N/A
- P/E Ratio
- HNST $65.02
- ATXS N/A
- Revenue Growth
- HNST 9.58
- ATXS N/A
- 52 Week Low
- HNST $3.32
- ATXS $3.56
- 52 Week High
- HNST $8.97
- ATXS $12.92
- Technical
- Relative Strength Index (RSI)
- HNST 45.50
- ATXS 65.14
- Support Level
- HNST $3.79
- ATXS $7.12
- Resistance Level
- HNST $3.99
- ATXS $7.91
- Average True Range (ATR)
- HNST 0.14
- ATXS 0.44
- MACD
- HNST 0.03
- ATXS 0.11
- Stochastic Oscillator
- HNST 40.72
- ATXS 90.51
About HNST The Honest Company Inc.
The Honest Co Inc is a digitally-native consumer products company to makes purpose-driven consumer products designed for all people. It is an omnichannel brand, ensuring its products are available wherever its consumers shop through the company's Retail and Digital channels. It has three product categories namely; Diapers and Wipes, Skin and Personal Care, and Household and Wellness, out of which the majority of its revenue is generated from the sale of diapers and wipes. The company operates only in the United States.
About ATXS Astria Therapeutics Inc.
Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Their second product candidate is STAR-0310, a monoclonal antibody OX40 antagonist that is in preclinical development for the treatment of atopic dermatitis, or AD, an immune disorder associated with loss of skin barrier function and itching.